Buckley Jr., William F.
February 1978
National Review;2/3/1978, Vol. 30 Issue 5, p173
The article comments on the crusade of the Committee on Treatment of Inctractable Pain led by Judith Quattlebaum. The objective of the committee is to permit the licensing of the heroin drug for its manufacture and administration in the United States for terminal cancer patients. Doctors agree that heroin can do more than morphine because it produces a higher level of euphoria and it makes hydrochloride solution more soluble that a small dosage can abort extreme pain.


Related Articles

  • MRS. Q. THE PAIN KILLER. Buckley Jr., WM. F. // National Review;7/11/1980, Vol. 32 Issue 14, p860 

    This article considers a bill proposed by the National Committee on the Treatment of Intractable Pain, launched by Judith Quattlebaum, that would permit the use of heroin for patients dying of terminal cancer and facing pain. The U.S. government refuses to authorize any use of heroin. It instead...

  • FIXED UP.  // New Scientist;3/30/2002, Vol. 173 Issue 2336, p34 

    Focuses on the use of heroin to treat heroin addicts. Prescription of heroin to heroin addicts; Effect of heroin to the human system; Controversy on heroin prescription for heroin addicts. INSET: A new cure?.

  • THE CASE OF THE TAINTED HEROIN. Langston, J. William // Sciences;Jan/Feb85, Vol. 25 Issue 1, p34 

    Focuses on the nature of Parkinson's Disease. Symptoms of the disease; Breakthroughs in the treatment of the disease; Effects of heroin intake on Parkinson's disease patient.

  • The Swiss heroin trials: Testing alternative approaches. Farrell, Michael; Hall, Wayne // BMJ: British Medical Journal (International Edition);02/28/98, Vol. 316 Issue 7132, p639 

    Studies heroin prescription as an alternative approach against the prescription of injectable opioid drugs. Details on the heroin study conducted in Switzerland; Controversies surrounding the Swiss trial; Debate about heroin prescription in Australia.

  • Heroin-assisted treatment: no difference in treatment retention. Al-Adwani, A.; Nahata, R.; Haasen, C. // British Journal of Psychiatry;Nov2007, Vol. 191, p458 

    A letter to the editor is presented in response to an article about heroin-assisted treatment.

  • Heroin trial gets green light.  // Lamp;Nov2013, Vol. 70 Issue 10, p8 

    The article reports that Health Canada has authorized doctors in British Columbia to prescribe heroin for patients who are unable to respond to conventional addiction treatments.

  • Dutch plan to prescribe heroin for long term misusers. Sheldon, Tony // BMJ: British Medical Journal (International Edition);10/22/94, Vol. 309 Issue 6961, p1036 

    Reports the plans of doctors to prescribe heroin to drug misusers in the Netherlands. Assessment on the critical medical condition of long-time drug users; Prescription of small amounts of heroin as part of social rehabilitation programs; Attempts to find solutions to crimes associated with...

  • Method for the Quantification of Diamorphine and its Metabolites in Pediatric Plasma Samples by Liquid Chromatography – Tandem Mass Spectrometry⋆. AI-Asmari, Ahmed; Anderson, Robert A.; Kidd, Susan; Thomson, AIison H. // Journal of Analytical Toxicology;May2010, Vol. 34 Issue 4, p177 

    The article presents a study on identification and quantification of diamorphine (DIM) and its metabolites in pediatric plasma samples by liquid chromatography. The study investigates using plasma samples obtained from childrens who were in treatment for acute-to-severe-pain. Results of the...

  • Heroin-assisted treatment: has a controversial treatment come of age? Farrell, Michael; Hall, Wayne // British Journal of Psychiatry;Jul2015, Vol. 207 Issue 1, p3 

    An introduction to the journal is presented in which the editors discuss heroin-assisted treatment of heroin dependence.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics